St. Luke’s & Roosevelt Hospitals and SHARE Receive Grant From Komen Greater New York City Affiliate

This grant is for the patients who are not medically supplied financially, biologically, culturally, in the area of linguistics and in the need to overcome these obstacles

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

New York, NY (PRWEB) June 25, 2012

The Greater New York City Affiliate of Susan G. Komen for the Cure® (Komen Greater NYC) recently awarded the St. Luke’s and Roosevelt Hospital Breast Clinic with a grant in the amount of $88,121 for the hospital’s Breast Cancer Continuum of Care Program. This program, offered in collaboration with SHARE: Self-help for Women with Breast or Ovarian Cancer, enables us to fight health care disparities with diverse medically under-served women who face many barriers in accessing timely quality care for both a breast cancer diagnosis and treatment after a diagnosis is made.

“This grant means a great deal for the patients here, most of who are medically underserved and have to overcome a number of financial, linguistic, cultural, and biological obstacles to receive access to medical services and quality care,” said AyeMoe Thu Ma, MD, Director of St. Luke’s Breast Surgery Division at St. Luke’s and Roosevelt Hospital Center. “It will help support services to ensure that diagnostic tests and treatments are conducted in a timely manner and with emotional support that patients need during each procedure, which in turn, increases her adherence and timeliness.”

“At the Komen Greater New York City Affiliate, we conducted a needs assessment of our community and discovered that Asian and Hispanic woman face enormous barriers in navigating the health care system,” said Anita R. McFarlane, MPH, Komen Greater NYC Director of Grants & Public Policy. “We are confident that through St. Luke’s and Roosevelt Hospital Center’s Breast Cancer Continuum of Care Program, Asian and Hispanic women will be able to make informed decisions about their care.”

Through the inter-disciplinary team that this grant from Komen Greater NYC makes possible, the St. Luke’s clinic has the resources to help patients have the best health outcome possible in a timely manner through comprehensive services across the continuum of a breast cancer diagnosis. The financial support of this grant will fund the SHARE Bi-lingual Survivor Patient Navigator (SPN) trained and a Multi-lingual Patient Advocate (PA), who will be able to provide patients with needed medical information in their native language (whether it is English, Spanish or Mandarin), and who can provide the emotional support and information to assist a patient in making informed decisions about her health and adhere to her treatment plan. These patient advocates encourage and educate them so that each woman will make informed medical decisions based on scientific and medical information, rather than fear, misunderstanding or a cultural myth.

These patient advocates encourage and educate them so that each woman will make informed medical decisions based on scientific and medical information, rather than based in fear, misunderstanding or a cultural myth.

“At St. Luke’s and Roosevelt Hospital, we believe in offering comprehensive, individualized and the most advanced care to all patients in culturally competent manner, regardless of their insurance status,” said Dr. Ma.

“SHARE has been providing support to underserved patients at hospital breast clinics through our Survivor/Patient Navigator program for 15 years,” said Ivis Sampayo, Senior Director of Programs at SHARE, a 36-year-old nonprofit organization that supports, educates, and empowers people affected by breast or ovarian cancer. “We’re so happy to get the opportunity to collaborate once again with St. Luke’s and Roosevelt Hospital to show patients the face of survivorship at the moment they learn they have breast cancer and to help them make informed decisions about their care.”

Ultimately, through the patient advocate support provided through this grant from Komen Greater NYC, patients will be able to learn to be their own advocates and lead healthier lives through this experience.

About Susan G. Komen for the Cure and the Komen Greater New York City Affiliate
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever, and in 1982, that promise became Susan G. Komen for the Cure. The Greater New York City Affiliate is part of the world’s largest and most progressive grassroots network fighting breast cancer. Through events like the Komen Greater NYC Race for the Cure, the Greater New York City Affiliate has invested $3.0 million in community breast cancer programs in New York City, Long Island, Westchester and Rockland Counties. Up to 75 percent of net proceeds generated by the Affiliate stays in the greater New York City metropolitan area. The remaining 25 percent funds national breast cancer research. In 2012, Komen Greater NYC invested $1.4 million in research to find the cures. For more information, call 212-293 CURE or visit http://www.komennyc.org.

Susan G. Komen for the Cure is the world’s largest breast cancer organization, and the Greater New York City Affiliate is number one out of the 125 Affiliates on the front lines dedicated to ending breast cancer in their communities. Komen Affiliates fund innovative programs that help women and men overcome the cultural, social, educational and financial barriers to breast cancer screening and treatment.

About St. Luke’s and Roosevelt Hospital Cancer Center
Continuum Cancer Centers of New York – located at Beth Israel Medical Center, St. Luke’s and Roosevelt Hospitals and The New York Eye and Ear Infirmary- include some of the most widely respected oncology programs in the city and country, where we care for more than 6,000 new patients each year and follow more than 24,000 cancer survivors. Continuum Cancer Centers remains the only hospital system in the metropolitan area to earn network accreditation with commendation by the American College of Surgeons Commission on Cancer.

Pioneering research by our clinicians in head and neck, prostate, breast, gastrointestinal and hepatobiliary cancers have helped shape modern cancer care in the United States. Currently we are conducting more than 60 clinical trials and leading research on integrative oncology, survivorship, prevention and outcomes. Our commitment to integrative oncology and the patient experience has gained widespread attention and commendation. Our physicians are leaders in non-invasive and minimally invasive cancer treatments that focus on maximizing both the cure rate and quality of life.


Contact

  • Jeff Jacomowitz
    jjacomo@chpnet.org
    212.523.6069
    Email